MedTrace Logo

Study of a Polymorphism in Patients With Prostate Cancer

NCT00900185 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 750

Last updated 2015-04-30

No results posted yet for this study

Summary

RATIONALE: Studying samples of blood from patients with cancer and from healthy participants in the laboratory may help doctors learn more about changes that may occur in DNA.

PURPOSE: This laboratory study is looking at blood samples from patients with prostate cancer and from healthy participants to identify a polymorphism that may help in the study of prostate cancer.

Conditions

Interventions

GENETIC

mutation analysis

GENETIC

polymerase chain reaction

GENETIC

polymorphism analysis

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    lead NIH

Principal Investigators

  • William D. Figg, PharmD · National Cancer Institute (NCI)

Eligibility

Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00900185 on ClinicalTrials.gov